|
|||||
|
|
Safety analysis of Lexiva tablets 700 (fosamprenavir calcium hydrate) in post-marketing surveillance in Japan |
|
| Authors: | Akiko Fukuda Takako Nagao Tomomi Kitaichi Akihiro Kobayashi Toshiyuki Miura |
| Affiliation: | 1. ViiV Healthcare K.K, Tokyo, Japan;2. Biomedical Data Sciences Department, GlaxoSmithKline K.K, Tokyo, Japan |
| Abstract: | |
| Keywords: | Adverse drug reaction fosamprenavir human immunodeficiency virus post-marketing surveillance |